TTM
$930.40M
YoY change
+45.1%
5Y CAGR
+11.1%
Peak year (2025)
$836.30M
Cumulative net income
$2.53B
Net Income history chart for DexCom (DXCM) from 2000 to 2025
Latest: $836.30M
Net Income growth chart for DexCom (DXCM) from 2000 to 2025
Latest: +45.1%
Net Income history table for DexCom (DXCM) from 2000 to 2025
| 2025 | $836.30M | +45.1% | +$260.10M | ||
| 2024 | $576.20M | +6.4% | +$34.70M | ||
| 2023 | $541.50M | +58.7% | +$200.30M | ||
| 2022 | $341.20M | +57.3% | +$124.30M | ||
| 2021 | $216.90M | -56.1% | −$276.70M | ||
| 2020 | $493.60M | +388.2% | +$392.50M | ||
| 2019 | $101.10M | -179.5% | +$228.20M | ||
| 2018 | −$127.10M | +153.2% | −$76.90M | ||
| 2017 | −$50.20M | -23.5% | +$15.40M | ||
| 2016 | −$65.60M | +13.9% | −$8.00M | ||
| 2015 | −$57.60M | +157.1% | −$35.20M | ||
| 2014 | −$22.40M | -24.8% | +$7.40M | ||
| 2013 | −$29.80M | -45.3% | +$24.70M | ||
| 2012 | −$54.50M | +21.8% | −$9.75M | ||
| 2011 | −$44.75M | -18.9% | +$10.42M | ||
| 2010 | −$55.17M | +3.1% | −$1.65M | ||
| 2009 | −$53.52M | -3.0% | +$1.66M | ||
| 2008 | −$55.18M | +20.3% | −$9.31M | ||
| 2007 | −$45.88M | -1.5% | +$721.29K | ||
| 2006 | −$46.60M | +51.5% | −$15.83M | ||
| 2005 | −$30.77M | +120.6% | −$16.82M | ||
| 2004 | −$13.95M | +40.7% | −$4.03M | ||
| 2003 | −$9.91M | +28.6% | −$2.21M | ||
| 2002 | −$7.71M | +22.9% | −$1.44M | ||
| 2001 | −$6.27M | +58.2% | −$2.31M | ||
| 2000 | −$3.96M | — | — |
- 2025$836.30M+45.1%
- 2024$576.20M+6.4%
- 2023$541.50M+58.7%
- 2022$341.20M+57.3%
- 2021$216.90M-56.1%
- 2020$493.60M+388.2%
- 2019$101.10M-179.5%
- 2018−$127.10M+153.2%
- 2017−$50.20M-23.5%
- 2016−$65.60M+13.9%
- 2015−$57.60M+157.1%
- 2014−$22.40M-24.8%
- 2013−$29.80M-45.3%
- 2012−$54.50M+21.8%
- 2011−$44.75M-18.9%
- 2010−$55.17M+3.1%
- 2009−$53.52M-3.0%
- 2008−$55.18M+20.3%
- 2007−$45.88M-1.5%
- 2006−$46.60M+51.5%
- 2005−$30.77M+120.6%
- 2004−$13.95M+40.7%
- 2003−$9.91M+28.6%
- 2002−$7.71M+22.9%
- 2001−$6.27M+58.2%
- 2000−$3.96M—
Net Income values are taken from DexCom's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current net income (TTM) is $930.40M. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, DexCom (DXCM) net income totalled $836.30M – surged 45.1% year-over-year.
DexCom net income compound annual growth for the 2020–2025 (5 years) window is +11.1%, sustaining 4 straight years of year-over-year growth.
The record annual net income stands at $836.30M, reached in 2025; the historical low of −$127.10M was recorded in 2018.
DexCom Net Income by Year
DexCom Net Income 2025: $836.30M
DexCom net income in 2025 was $836.30M, surged 45.1% from 2024. This figure represents the highest annual value in the available history.
DexCom Net Income 2024: $576.20M
2024's net income for DexCom came in at $576.20M, grew 6.4% from 2023.
DexCom Net Income 2023: $541.50M
DexCom posted net income of $541.50M in 2023, surged 58.7% from 2022.
DexCom Net Income 2022: $341.20M
In 2022, DexCom reported net income of $341.20M, surged 57.3% from 2021.
DexCom Net Income 2021: $216.90M
DexCom net income in 2021 was $216.90M.
See more financial history for DexCom (DXCM).
Sector peers by Net Income
Healthcare peers of DexCom (DXCM), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation